These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8263783)

  • 41. Combined administration of oxalic acid, succimer and its analogue for the reversal of gallium arsenide-induced oxidative stress in rats.
    Flora SJ; Kannan GM; Pant BP; Jaiswal DK
    Arch Toxicol; 2002 Jun; 76(5-6):269-76. PubMed ID: 12107644
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mobilization of heavy metals by newer, therapeutically useful chelating agents.
    Aposhian HV; Maiorino RM; Gonzalez-Ramirez D; Zuniga-Charles M; Xu Z; Hurlbut KM; Junco-Munoz P; Dart RC; Aposhian MM
    Toxicology; 1995 Mar; 97(1-3):23-38. PubMed ID: 7716789
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 2,3-Dimercaptopropanol, 2,3-dimercaptopropane-1-sulfonic acid, and meso-2,3-dimercaptosuccinic acid inhibit delta-aminolevulinate dehydratase from human erythrocytes in vitro.
    Nogueira CW; Santos FW; Soares FA; Rocha JB
    Environ Res; 2004 Mar; 94(3):254-61. PubMed ID: 15016592
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protective effects of thiol containing chelating agents against liver injury induced by hexavalent chromium in mice.
    Ueno S
    Kitasato Arch Exp Med; 1992 Sep; 65(2-3):87-96. PubMed ID: 1339196
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Urinary excretion of meso-2,3-dimercaptosuccinic acid in human subjects.
    Aposhian HV; Maiorino RM; Dart RC; Perry DF
    Clin Pharmacol Ther; 1989 May; 45(5):520-6. PubMed ID: 2541962
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effect of dimercaptosuccinic acid per os on distribution and excretion of 210Pb and 203Hg in mice].
    Liang YY; Zhang JS; Tao ZQ; Yan XM; Xu XH; Chen ZJ
    Zhongguo Yao Li Xue Bao; 1994 Jul; 15(4):379-82. PubMed ID: 7801787
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selection of micronutrients used along with DMSA in the treatment of moderately lead intoxicated mice.
    Liao Y; Yu F; Jin Y; Lu C; Li G; Zhi X; An L; Yang J
    Arch Toxicol; 2008 Jan; 82(1):37-43. PubMed ID: 17721779
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reversal of arsenic-induced hepatic apoptosis with combined administration of DMSA and its analogues in guinea pigs: role of glutathione and linked enzymes.
    Mishra D; Mehta A; Flora SJ
    Chem Res Toxicol; 2008 Feb; 21(2):400-7. PubMed ID: 18163546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of L-cysteine, L-cysteine derivatives and ascorbic acid on lead excretion in rats.
    McNiff EF; Cheng LK; Woodfield HC; Fung HL
    Res Commun Chem Pathol Pharmacol; 1978 Apr; 20(1):131-7. PubMed ID: 663395
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of liposome-encapsulated meso-2,3-dimercaptosuccinic acid on mice exposed to lead through drinking water.
    Misra M; Behari JR
    Boll Chim Farm; 1997 Nov; 136(10):611-4. PubMed ID: 9528168
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lead detoxification activities of a class of novel DMSA--amino acid conjugates.
    Xu Y; Wang Y; Wang L; Zhao M; Zhang X; Hu X; Hou B; Peng L; Zheng M; Wu J; Peng S
    Chem Res Toxicol; 2011 Jun; 24(6):979-84. PubMed ID: 21591669
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduction of lead retention by mono-3-methylbutan-1-yl meso-2,3-dimercaptosuccinate in suckling rats.
    Blanusa M; Kostial K; Piasek M; Jones MM; Singh PK
    Analyst; 1995 Mar; 120(3):951-3. PubMed ID: 7741262
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Changes in brain biogenic amines and haem biosynthesis and their response to combined administration of succimers and Centella asiatica in lead poisoned rats.
    Saxena G; Flora SJ
    J Pharm Pharmacol; 2006 Apr; 58(4):547-59. PubMed ID: 16597373
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mobilization of lead by esters of meso-2,3-dimercaptosuccinic acid.
    Singh PK; Jones MM; Xu Z; Gale GR; Smith AB; Atkins LM
    J Toxicol Environ Health; 1989; 27(4):423-34. PubMed ID: 2547977
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oral succimer decreases the gastrointestinal absorption of lead in juvenile monkeys.
    Cremin JD; Luck ML; Laughlin NK; Smith DR
    Environ Health Perspect; 2001 Jun; 109(6):613-9. PubMed ID: 11445516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cadmium inhibits delta-aminolevulinate dehydratase from rat lung in vitro: interaction with chelating and antioxidant agents.
    Luchese C; Zeni G; Rocha JB; Nogueira CW; Santos FW
    Chem Biol Interact; 2007 Jan; 165(2):127-37. PubMed ID: 17187767
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 2,3-Dimercaptopropanol, 2,3-dimercaptopropane-1-sulfonic acid and meso-2,3-dimercaptosuccinic acid increase lead-induced inhibition of delta-aminolevulinate dehydratase in vitro and ex vivo.
    Santos FW; Rocha JB; Nogueira CW
    Toxicol In Vitro; 2006 Apr; 20(3):317-23. PubMed ID: 16168622
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human studies with the chelating agents, DMPS and DMSA.
    Aposhian HV; Maiorino RM; Rivera M; Bruce DC; Dart RC; Hurlbut KM; Levine DJ; Zheng W; Fernando Q; Carter D
    J Toxicol Clin Toxicol; 1992; 30(4):505-28. PubMed ID: 1331491
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reversal of lead-induced oxidative stress by chelating agent, antioxidant, or their combination in the rat.
    Tandon SK; Singh S; Prasad S; Srivastava S; Siddiqui MK
    Environ Res; 2002 Sep; 90(1):61-6. PubMed ID: 12359191
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tissue decorporation of polonium-210 in rats by DMPA.
    Aposhian HV; Dart RC; Aposhian MM; Dawson BV
    Res Commun Chem Pathol Pharmacol; 1987 Nov; 58(2):157-71. PubMed ID: 2827276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.